Lobbying client · LD-2 disclosures
Partner Therapeutics
Massachusetts
40 filings from 3 registrants · 2021–2026 · latest filed Jul 16, 2026
Reported on its behalf
$2.1M
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$2.1M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
40 filings
$2.1M on those filings
Budget/Appropriations
BUD
19 filings
$855K on those filings
Defense
DEF
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Sara Love Rawlings Sl Strategies, LLCCovered position: U.S. Senate Committee on Appropriations20 filingsthrough 2026
- Jordan Tenenbaum Sl Strategies, LLC20 filingsthrough 2026
- Christopher Putala PutalastrategiesCovered position: Professional Staff, Senate Judiciary Committee19 filingsthrough 2026
- Mary Moody Johnson Sl Strategies, LLCCovered position: U.S. Senate Committee on Health, Education, Labor and Pensions7 filings
The filings
The 20 most recent of 40 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: partner-therapeutics.